JCS 2018 guideline on diagnosis and treatment of acute coronary syndrome

K Kimura, T Kimura, M Ishihara, Y Nakagawa… - Circulation …, 2019 - jstage.jst.go.jp
Acute coronary syndromes (ACS) are a comprehensive disease concept characterized by
acute myocardial ischemia caused by disruption of coronary artery plaque and consequent …

Beta-blockers for the treatment of arrhythmias: Bisoprolol–a systematic review

L Muresan, G Cismaru, C Muresan, R Rosu… - Annales …, 2022 - Elsevier
Objectives Beta-blockers have long been successfully used for the treatment of both
supraventricular and ventricular arrhythmias. However, differences exist between their …

Role of β-blockers in the cardiovascular disease continuum: a collaborative Delphi survey-based consensus from Asia-Pacific

S Ray, T Nair, J Sawhney, Erwinanto… - Current Medical …, 2023 - Taylor & Francis
Abstract Objective This Delphi method of consensus was designed to develop scientific
statements for β-blockers in the continuum of cardiovascular diseases with a special focus …

[HTML][HTML] Sudden cardiac death in patients with myocardial infarction: 1.5 primary prevention

YT Feng, XF Feng - Reviews in Cardiovascular Medicine, 2021 - imrpress.com
Sudden cardiac death (SCD) is one of the most common causes of death in the world.
Coronary heart disease (CHD) is the root cause of most patients with SCD, and myocardial …

[Retracted] The Efficacy and Safety of Bisoprolol in the Treatment of Myocardial Infarction with Cardiac Insufficiency

Y Wang - Computational and Mathematical Methods in …, 2022 - Wiley Online Library
Background. Bisoprolol is commonly used to treat moderate or severe chronic stable heart
failure, coronary heart disease, and hypertension. This study is aimed at analyzing the …

Population pharmacokinetic analysis of bisoprolol in patients with acute coronary syndrome

S Momčilović, JR Milovanović… - Journal of …, 2019 - journals.lww.com
To date, many questions about the extent and cause of pharmacokinetic (PK) variability of
even the most widely studied and prescribed β1-adrenergic receptor blockers, such as …

Sudden cardiac death in acute coronary syndromes

N Dagres, G Hindricks - Cardiac Electrophysiology Clinics, 2017 - cardiacep.theclinics.com
Sudden cardiac death is a major cause of mortality in acute coronary syndromes, mostly
caused by complex ventricular arrhythmias, in particular, ventricular fibrillation (VF). This …

Долгожданная комбинация бета-блокатора и ингибитора ангиотензинпревращающего фермента: новые возможности в оптимизации лечения пациентов с …

ЮН Сиренко, ЕА Торбас - Артериальная гипертензия, 2017 - cyberleninka.ru
В обзоре представлена информация о фиксированной комбинации бета-
адреноблокатора бисопролола и ингибитора АПФ периндоприла. Детально …

Довгоочікувана комбінація бета-блокатора та інгібітора ангіотензинперетворюючого ферменту: нові можливості в оптимізації лікування пацієнтів із серцево …

YM Sirenko, OO Torbas - HYPERTENSION, 2017 - hypertension.zaslavsky.com.ua
Довгоочікувана комбінація бета-блокатора та інгібітора ангіотензинп Page 1 N¹ 4 (54),
2017 www.mif-ua.com, http://hypertension.zaslavsky.com.ua 9 REVIEW ОГЛЯД © «Артеріальна …